S
Satoshi Konno
Researcher at Hokkaido University
Publications - 255
Citations - 4551
Satoshi Konno is an academic researcher from Hokkaido University. The author has contributed to research in topics: Medicine & Asthma. The author has an hindex of 29, co-authored 212 publications receiving 3320 citations. Previous affiliations of Satoshi Konno include Japan Agency for Medical Research and Development & Nagasaki University.
Papers
More filters
Journal ArticleDOI
Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline
Fernando Holguin,Juan Carlos Cardet,Kian Fan Chung,Sarah Diver,Diogenes S. Ferreira,Diogenes S. Ferreira,Anne M. Fitzpatrick,Mina Gaga,Liz Kellermeyer,Sandhya Khurana,Shandra L Knight,Vanessa M. McDonald,Rebecca L. Morgan,Victor E. Ortega,David Rigau,Padmaja Subbarao,Thomy Tonia,Ian M. Adcock,Eugene R. Bleecker,Christopher E. Brightling,Louis-Philippe Boulet,Michael D. Cabana,Mario Castro,Pascal Chanez,Adnan Custovic,Ratko Djukanovic,Urs Frey,Betty Frankemölle,Peter G. Gibson,Dominique Hamerlijnck,Nizar N. Jarjour,Satoshi Konno,Huahao Shen,Cathy Vitary,Andrew Bush +34 more
TL;DR: Clinical recommendations for the management of severe asthma are provided and the use of novel therapies for severe asthma, specifically biologicals for type 2 high asthma, and antimuscarinic agents and macrolides, as well as on biomarkers for predicting treatment response are made.
Journal ArticleDOI
Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease
Masaharu Nishimura,Hironi Makita,Katsura Nagai,Satoshi Konno,Yasuyuki Nasuhara,Masaru Hasegawa,Kaoruko Shimizu,Tomoko Betsuyaku,Yoichi M. Ito,Satoshi Fuke,Takeshi Igarashi,Yasushi Akiyama,Shigeaki Ogura +12 more
TL;DR: Emmphysema severity is independently associated with a rapid annual decline in FEV1 in COPD, and the Sustainers and Rapid decliners warrant specific attention in clinical practice.
Journal ArticleDOI
IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity.
Mio Kawaguchi,Daisuke Takahashi,Nobuyuki Hizawa,Shintaro Suzuki,Satoshi Matsukura,Fumio Kokubu,Yukiko Maeda,Yoshinobu Fukui,Satoshi Konno,Shau Ku Huang,Masaharu Nishimura,Mitsuru Adachi +11 more
TL;DR: Genetic analyses of association of asthma with the common variants of IL17F indicate that the IL-17F H161R variant influences the risk of asthma and is a natural IL- 17F antagonist, suggesting a potential role for IL-16F in the etiology of asthma.
Journal ArticleDOI
Comparison of SARS-CoV-2 detection in nasopharyngeal swab and saliva.
Sumio Iwasaki,Shinichi Fujisawa,Sho Nakakubo,Keisuke Kamada,Yu Yamashita,Tatsuya Fukumoto,Kaori Sato,Satoshi Oguri,Keisuke Taki,Hajime Senjo,Junichi Sugita,Kasumi Hayasaka,Satoshi Konno,Mutsumi Nishida,Takanori Teshima +14 more
TL;DR: In this article, the efficacy of PCR detection of SARS-CoV-2 between paired nasopharyngeal and saliva samples in nine COVID-19 patients was evaluated.
Journal ArticleDOI
A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma.
TL;DR: Evidence of the importance of the -28G allele was a significant increase in the production of RANTES in vitro in individuals who carried this allele, suggesting susceptibility to late-onset asthma among Japanese patients.